Literature DB >> 17667936

Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.

Tanya M Watters1, Elaine F Kenny, Luke A J O'Neill.   

Abstract

The Toll/IL-1 receptor (TIR) domain plays a central role in Toll-like receptor (TLR) signalling. All TLRs contain a cytoplasmic TIR domain, which, upon activation, acts as a scaffold to recruit adaptor proteins. The adaptor proteins MyD88, Mal, TRIF, TRAM and SARM are also characterized by the presence of a TIR domain. MyD88, Mal, TRIF and TRAM associate with the TLRs via homophilic TIR domain interactions whereas SARM utilizes its TIR domain to negatively regulate TRIF. It is well established that the differential recruitment of adaptors to TLRs provides a significant amount of specificity to the TLR-signalling pathways. Despite this, the TIR-TIR interface has not been well defined. However, structural studies have indicated the importance of TIR domain surfaces in mediating specific TIR-TIR interactions. Furthermore, recent findings regarding the regulation of adaptors provide further insight into the crucial role of the TIR domain in TLR signalling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667936     DOI: 10.1038/sj.icb.7100095

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  78 in total

1.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.

Authors:  Ryan Ferrao; Jixi Li; Elisa Bergamin; Hao Wu
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

Review 3.  The Immune System and the Role of Inflammation in Perinatal Depression.

Authors:  Philippe Leff-Gelman; Ismael Mancilla-Herrera; Mónica Flores-Ramos; Carlos Cruz-Fuentes; Juan Pablo Reyes-Grajeda; María Del Pilar García-Cuétara; Marielle Danitza Bugnot-Pérez; David Ellioth Pulido-Ascencio
Journal:  Neurosci Bull       Date:  2016-07-18       Impact factor: 5.203

Review 4.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

5.  Negative control of TLR3 signaling by TICAM1 down-regulation.

Authors:  Shasha Tao; Lingxiang Zhu; Pakkei Lee; Wai-ming Lee; Kenneth Knox; Jie Chen; Yuanpu Peter Di; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-28       Impact factor: 6.914

6.  Functional diversification of the toll-like receptor gene family.

Authors:  Austin L Hughes; Helen Piontkivska
Journal:  Immunogenetics       Date:  2008-04-16       Impact factor: 2.846

Review 7.  Sensors of the innate immune system: their mode of action.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Brian R Lawson; Michael E Stern; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Nat Rev Rheumatol       Date:  2009-07-14       Impact factor: 20.543

8.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

9.  MCPIP1 negatively regulates toll-like receptor 4 signaling and protects mice from LPS-induced septic shock.

Authors:  Shengping Huang; Ruidong Miao; Zhou Zhou; Tianyi Wang; Jianguo Liu; Gang Liu; Y Eugene Chen; Hong-Bo Xin; Jifeng Zhang; Mingui Fu
Journal:  Cell Signal       Date:  2013-02-17       Impact factor: 4.315

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.